DURHAM, N.C. (WNCN) – Quintiles Founder Dr. Dennis Gillings will retire from his position as executive chairman of Quintiles Transnational Holdings Inc. Dec. 31, the company announced Thursday.
Gillings will remain on the board as a director. The board has appointed Jack M. Greenberg to serve as Chairman of the Board, effective January 1, 2016.
Gillings began performing biostatical analysis work for pharmaceutical companies with a single project in 1974 while still a professor of biostatistics at the University of North Carolina at Chapel Hill. That small consulting business, which would become Quintiles, began with a handful of staff working out of a trailer on the UNC campus.
Quintiles was incorporated as a privately held company in 1982, and now has nearly 35,000 employees conducting business in 100 countries.
Gillings took Quintiles public through its first Initial Public Offering in 1994, and a second IPO in 2013. Gillings served as Quintiles CEO for nearly all of the company’s first 30 years of operation until current CEO Tom Pike joined the company in 2012.